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Abstract
Background: Transient ischemic attack (TIA) is described as a brief episode of neurological
dysfunction caused by focal brain ischemia, with clinical symptoms typically lasting less than an hour,
and without evidence of acute infarction. Recent studies depict TIA as a particularly unstable
condition. Risk of stroke is greater than 10% in the first 90 days after an index TIA. The
presentation, prognosis and intervention for TIA have not been reported in South-Asians in a
developing country.
Method: A retrospective chart review was done for 158 patients who were admitted with the
diagnosis of TIA, as defined by ICD 9 code 435, from January 2003 to December 2005 at the Aga
Khan University Hospital, Karachi, Pakistan. The data was entered and analyzed in SPSS version
14.0.
Findings: Among 158 patients, 57.6% were male and 41.1% were female. The common presenting
symptoms were motor symptoms (51.3%), speech impairment (43%), sensory impairment (34.8%)
and loss of balance/vertigo (29.1%). The median delay in presenting to the hospital was 4 hours.
Those with motor symptoms were found to present earlier. The study showed that only 60.8% of
all the patients presenting with TIA received any immediate treatment out of which 44.7% received
aspirin. Neuroimaging was used in 91.1% of the patients. Of all the TIA patients 9.1% converted to
stroke with 50% doing so within the first 24 hours.
Conclusion: The natural history of TIA from this developing nation is comparable to international
descriptions. A large percentage of patients are still not receiving any immediate treatment as
recommended in available guidelines, even in a tertiary care hospital.

Background
Transient Ischemic attacks (TIA) represent an opportunity
to prevent strokes. Although the risk factors, evaluation
and secondary prevention of TIA and stroke are comparable, TIA is conventionally considered a less urgent mani-

festation and therefore receives leisurely intervention
[1,2]. Whether an intervention can prevent the development of stroke in patients presenting with TIA, has been
an area of significant debate and research. In the interim,
given the natural history, proper care and management
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should be provided to all patients with TIA [3,4]. The
EXPRESS study has shown that early initiation of existing
treatments after TIA or minor stroke was associated with
an 80% reduction in the risk of early recurrent stroke [5].
TIA has been described as a stroke that lasts less than 24
hours. The American TIA Working Group proposed a new
definition which states that a transient ischemic attack is a
brief episode of neurologic dysfunction, caused by local
brain or retinal ischemia, with clinical symptoms typically
lasting less than one hour, and without evidence of cerebral infarction[6]. The early estimated risk of stroke after a
TIA is 8–12% at seven days and 11–15% at one month
[6,7]. A study from California done on the short term
prognosis of transient ischemic attacks revealed that in a
90 day period after a TIA, one in nine patients had a stroke
and half of all the strokes occurred in the first 2 days [8].
Stroke is the leading cause of sustained neurological disability in the world [9]. Two thirds of all strokes now occur
in the developing world. South Asia represents a quarter
of the emerging world and harbors 20% of the global
stroke population [9]. Approximately 15% of ischemic
strokes are preceded by a TIA [7]. Thus TIA represents an
intervention opportunity in those most at risk.
In Pakistan, non communicable disease now accounts for
41% of total disease burden. The National Health Survey
of Pakistan (NHSP) estimates that Hypertension – the single most preventable cause of stroke and TIA – affects one
in three adults aged greater than 45, and 19% of the population aged 15 and above. The NHSP showed that DM is
present in 35% of adults greater than 45 years of age [10].
Coronary artery disease can cause cardio embolic stroke
and is a surrogate for atherosclerosis in the cerebrovascular system: a population based cross sectional survey
showed a prevalence of 1 in 4 middle aged adults with
men and women at equal risk [11]. The overall prevalence
of obesity is 28% in women and 22% in men. The prevalence of tobacco use is 40% in men and 12% in women
[12]. Various other factors, like unhealthy dietary patterns, low socio-economic strata and genetic predisposition in certain population groups, have repeatedly been
identified [9,13-16]. Adding to this, other challenges like
the lack of knowledge of TIA symptomatology, diagnosis
and awareness of its serious implication at the primary
health care level, and where these patients may present to,
make the awareness and proper management of TIA
patients all the more important [17,18]. The presentation,
natural history and prognosis of TIAs are not known for
Pakistan, where the risk profile and population is very different from Caucasian cohorts.
The objective of this study is to describe the base line characteristics, presentation and the current management of
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TIA events in daily clinical practice in a tertiary care hospital in a developing country. This information would help
prevent stroke in those most at risk of developing this disease and will provide a comparison with findings from the
Western countries.

Methods
Study Design
A retrospective chart review was conducted for inpatients
who were admitted and diagnosed with TIA between January 2003 and December 2005 at the Aga Khan University
(AKU), a teaching hospital in Karachi, Pakistan. Patients
who were admitted and diagnosed with TIA, as defined by
ICD 9 code, were included in this study. The definition of
TIA was the sudden onset of neurologic deficit respecting
a vascular territory with resolution of symptoms within 24
hours. The majority of TIAs actually resolve within 60
minutes, and most of these resolve within 30 minutes.
Levy showed that the likelihood that symptoms will
resolve completely within 24 hours is less than 15 percent
if symptoms last more than 1 hour [19]. In the emergency
room, all patients who present with TIA are offered admission for 24 hours.

These patients were diagnosed with TIA by the neurologist
on service. The patients were evaluated in the emergency
room and admitted in the hospital via the emergency
room, or picked up as consultations from other in patient
services e.g. TIA on internal medicine service. The neurologic consultant assigned the vascular diagnosis and the
hospital coding service assigned the ICD 9 code number.
200 charts were selected after the approval of the Ethical
Review Committee (AKU-ERC). 35 charts were either irretrievable or had incomplete data and hence, were
excluded. Out of the remaining 165, seven were TIA mimics and not true cases of TIA, therefore these were
excluded.
Study Setting
This is a hospital based survey conducted at the Aga Khan
University Hospital (AKUH). AKUH is a tertiary care hospital in Karachi, Pakistan, with a total patient population
of 334,393 outpatients and 32,500 inpatients yearly.
Karachi is an urban city with a population of 20 million.
This study population reflects the reported TIA rates of a
non rural, multiethnic South Asian population in transition. During the study period (January 2003– December
2005) there were 1036 admissions for stroke. The stroke
and TIA admissions came from all over the city, and from
households that would be described as lower to middle
class urban city dwellers. Thus this study is generalisable
only as far as Asian "population in transition" (Omran's
Theory of rural population being urbanized) [20], which
may be most at risk for non communicable disease. In the
rural areas there are government run district health centers
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and the presentation and total numbers of TIAs are not
known for Pakistan. There is also a lack of community
based statistics.
Data collection tool
The main elements of the questionnaire, designed after a
thorough review of literature, were the presenting symptoms, co-morbid illnesses, history of use of anticoagulants
and antiplatelet agents, laboratory tests carried out, emergency room work up and the initial treatment, management in the stroke units and further follow-up of the
patients to a minimum of three months with new stroke
and its workup details. Risk factor definitions were

a) Hypertension defined either as:
1. Blood pressure >140/90 mmHg or >130/80 mmHg for
diabetic patients (before stroke or at least one week after
stroke), or
2. Known hypertension and being treated with antihypertensives [21].
b) Overweight: BMI 25.0 – 29.9 kg/m2 as defined by WHO
[22]
Obese: BMI ≥30.0 kg/m2 as defined by WHO [22].
c) Diabetes Mellitus as defined by any one of the following:
1. Fasting plasma glucose level at or above 126 mg/dL (7.0
mmol/l)
2. Plasma glucose at or above 200 mg/dL (11.1 mmol/l) 2
hours after a 75 gram oral glucose load as in a GTT.
3. Random plasma glucose at or above 200 mg/dL (11.1
mmol/l)
4. Known diabetic being treated with dietary modification, medication or both.
d) Smoker: >1 cigarette/day
Ex-smoker: Stopped smoking ≥2 years ago
e) Dyslipidemia defined as:
1. Known case of dyslipidemia on treatment or TG > 240
mg/dL
2. Hypercholesterolemia: LDL > 100 mg/dl [23].
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Data collection, analyses and follow up
The data was collected by the sub-investigators and then
entered and analyzed in SPSS 14.0. A qualified stroke neurologist classified the mechanism responsible for TIA
according to the TOAST classification [24].

Descriptive statistics were run for age, delay in presentation, and duration of hospital stay, radiological data and
laboratory tests. Cross-tabs were carried out and Chisquare tests were performed to find any association of
delay in presentation, symptom at presentation, age and
gender with management received, and for the comorbid
illnesses, risk factors and initial treatment received by the
TIA patients in the emergency room with recurrent TIA or
new stroke development.
All patients were given a 90 day follow up appointment in
the outpatient clinic and telephone contact was established with the patients so as to remind them of their follow up appointments. Since all charts in the hospital for a
single patient are linked (there are no separate inpatient
and outpatient charts) it is possible to review follow up
data as well.

Results
Among 158 patients, 57.6% were male and 41.1% were
female. The mean age of the patients was 60.23 ± 13.14
but the median age was 60, and the mode of the data for
age was 58. The most common presenting symptom was
motor impairment followed by speech difficulty. Table 1
depicts the presenting symptoms of the patient population. The median for the delay in presentation to the hospital was 4 hours and the mean was 20 hours and 46
minutes.
Table 2 depicts the comorbid illnesses and risk factors of
the patient population as well as a comparison with the
sub group that developed new stroke.
Table 3 depicts the immediate management and interventions received by the patients.
The most common type of TIA came out to be of undetermined and under investigated type (24.1%), followed
sequentially by presumable cardioembolic (20.3%), large

Table 1: Presenting symptoms of the patient cohort

Presenting symptoms

Frequency(%)

Motor symptoms
Sensory symptoms
Difficulty or loss of speech
Vertigo or loss of balance

51.3
34.8
43.0
29.1
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Table 2: A comparison of risk factors in TIA patients versus new stroke patients

Characteristics

Frequency(%)
TIA patients

Frequency(%)
New stroke patients

Hypertension
Diabetes
Stable angina
Unstable angina
Previous myocardial infarction
Congestive heart failure
Peripheral vascular disease
Hypercholesterolemia
Obesity
Coagulopathy
Atrial fibrillation
History of smoking
Prior use of at least one Medication (for any disease)

122(77.2)
61(38.6)
10(6.3)
9(5.7)
23(14.6)
5(3.2)
2(1.3)
72(45.6)
18(11.4)
6(3.8)
8(5.1)
33(20.9)
119(75.3)

12(80.0)
4(26.7)
2(13.3)
2(13.3)
0(0.0)
0(0.0)
5(33.3)
6(40.0)
1(6.7)
1(6.7)
1(6.7)
3(20.0)
13(86.7)

artery atherosclerosis (18.4%), probable lacunar warning
syndrome (15.8%) and truly undetermined (1.3%).
Out of the total 158 patients presenting with TIA, 9.5%
developed stroke in the first year. Among them, 50%
developed the stroke within 24 hours and 83.4% within
90 days following their initial TIA. All the strokes were
diagnosed in hospital. These were all ischemic strokes.
Although we did not look at ICH or SAH as predefined
outcomes, these were not reported in the small number of
outcome events that were studied.
Significant associations were found between male gender
and high LDL (p = 0.001), high triglycerides (p = 0.001)
Table 3: Immediate therapeutic and diagnostic interventions
performed on the patient population

Initial management

Frequency(%)

Percentage receiving any form of initial treatment
No immediate treatment
Initial aspirin
Other antiplatelet (Clopidogrel and Persantin)
Statins
Heparin
Low molecular weight heparin

60.8
39.2
27.2
12.7
1.9
6.3
8.2

Radiological diagnostic modalities

Frequency(%)

One or more radiological diagnostic modalities
MRI
Carotid dopplers
MRA
CT Scan
Echocardiography

91.1
53.2
47.5
41.8
27.2
57.6

Initial counseling

Frequency(%)

Documented counseling for smoking cessation

8.2

and positive history of smoking (p = 0.00). Increasing age
was found to be associated with more sensory symptoms
at presentation (p = 0.04). We found a significant association between the development of a new stroke after the
initial TIA event with positive history of unstable angina
(p = 0.00), high LDL, elevated triglycerides, low HDL (p =
0.01), time delay to presentation after onset of symptoms
(p = 0.003) and with the length of hospital stay (p =
0.042). There was a positive association between speech
symptoms at presentation and initial aspirin administration (p = 0.039). We found a negative association between
initial treatment with clopidogrel and heparin, with new
stroke (p = 0.021).
We did not find any significant association between new
stroke occurrence with administration of aspirin (p = 0.2)
or statin (p = 1.0) as an initial treatment in the emergency
room on presentation with TIA. This may be due to the
small number of outcome events.

Discussion
The high risk of stroke after a transient ischemic attack
supports an approach involving rapid evaluation and initiation of treatment. Consensus guidelines on the management of TIA have been promulgated by the American
Heart Association AHA and the National Stroke Association [3]. With regard to finding the cause and diagnosis of
TIA, our center has principally followed the AHA and NSA
guidelines. We found that about 91% of the patients were
diagnostically evaluated via at least one radiographic
imaging modality. These diagnostic tests were done to
identify or exclude etiologies of TIA requiring specific
therapy, to assess modifiable risk factors, and to determine prognosis. Head MRI and CT were done in 53.2%
and 27.2% of the cases respectively. The guidelines also
recommend imaging the carotid arteries in all cases but in
our study only 47.5% of patients underwent carotid imaging. The reason for the low number of carotid dopplers
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may be the perception held by the doctors that our population is different in terms of stroke causation. This perception is based on studies that suggest that Asians have
more intracranial atherosclerosis [25,26]. The figures for
neuroimaging are comparable with Western figures, as a
national study on emergency department visits for TIA in
the United States revealed that CT scan was performed on
56% patients and MRI on less than 5% of patients, though
over the period of the study there was an increase in the
trend to perform neuroimaging [27]. Another study conducted in 4 regional stroke centers in Ontario revealed
that diagnostic interventions were underutilized. CT scanning was performed in 58%, carotid Doppler ultrasonography in 44%, and MRI in 3% of patients [28].
Transient Ischemic attack, regarded as being the warning
sign for stroke needs prompt evaluation and management
[6]. Majority of the patients in our study were provided
robust evaluation but fewer received any immediate treatment, among which aspirin was the most common medicine administered. About 62.8% received immediate
treatment, of which 44% got aspirin(27.2% of the total)
while 19% got other anti-platelet medications. Statins and
heparin constituted only a meager 12% together. The use
of aspirin as an initial treatment is in accordance with the
AHA guidelines. Aspirin use in the early phase after stroke
or TIA reduces the risk of recurrence [29]. However, we did
not find any significant association between aspirin and
the risk of stroke in our study. This may be because our
sample size was very small with only 15 patients developing new stroke after the initial TIA. 39.2% of our patients
received no immediate medical treatment which compares with the national study on emergency department
TIA management in the United States in which 42% of
patients received no immediate medical treatment [27].
It has been reported in several studies that age > 60 yrs is
a risk factor for stroke after TIA. The ABCD and California
risk score systems have taken age > 60 yr as a significant
risk factor to predict future stroke after TIA [30]. Our study
did not find any association between age and stroke
occurrence. Although the mean age of our patients was
60.23 ± 13.14, but the median age was 60 and the mode
of the data for age was 58. This shows that in our region
much younger population suffers from TIA and stroke. We
attribute it to the dietary and genetic factors as previously
described. This aspect should be further explored in terms
of the factors behind this difference in the age at presentation.
The most common risk factors prevalent in descending
order of frequency were hypertension, hypercholesterolemia and diabetes respectively. This emphasizes the need
to address these co-morbid illnesses for secondary prevention of stroke. Smoking has been found to be associated
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with stroke. In our study 20.9% were smokers but the documented counseling for smoking cessation was done in
only 8.2% of the patients. This raises an important issue
regarding prevention of stroke. We propose that all the
smokers should be counseled for cessation in-hospital
and on outpatient follow-up visits. Such an approach
might help reduce the incidence of stroke among TIA
patients that is attributable to smoking.
Raised LDL and triglycerides were significantly associated
with male gender (p = 0.001). In our study more male
patients presented with TIA which is contrary to previous
studies which identify female gender as a risk factor. The
outcome of patients with TIA depends on a number of factors like the initial treatment received and comorbid illnesses. The delay in accessing hospital care and receiving
treatment is also important. Our study showed that
increased time delay of symptoms was associated with a
prolonged hospital stay (p = 0.042) and increased incidence of stroke (p = 0.003).
We were unable to deduce significant associations with
risk factors and the occurrence of new stroke, probably
because our sample size was small. We therefore recommend that further studies be carried out to find out various risk factors for stroke.
In our study, 9.5% of TIA patients developed stroke,
which is comparable to the international figure of 10.5%
stroke conversion. Our study, also verified the findings in
previous studies that the greatest risk of stroke after TIA is
in the first 48 hours. 9.5% of our patients developed
stroke and about 50% did so in the first 24 hours. There is
significant underutilization of investigative modalities
and the immediate medical management options for TIA.
This adds to the preexisting lack of attention to preventive
medicine. Data from Pakistan from the WHO_ PREMIS
study that looked at patients that accessed primary care
facilities – showed under utilization of prevention practices of quitting smoking, exercise, reduction of dietary
salt intake and limited use of aspirin (83%), B Blockers
(35%), ACEI (43%) and Statins (2.3%) [31]. This study
was limited to patients who visit outpatients facilities and
are likely to differ from the general population in their
health seeking behavior – the national situation regarding
prevention is likely to be far worse than this sample.
The stroke epidemic of the developing world disables
individuals in their prime of life, and is mostly preventable [32]. TIA represents an opportunity to intervene in
those most at risk. 50% of the stroke conversions in our
study occurred within the first 24 hours. A large percentage of these patients did not receive any immediate treatment. Hence a rapid evaluation is immensely important
to prevent stroke and permanent neurologic sequelae in
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these patients and to thwart the expanding stroke morbidity and mortality in the developing world.
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